{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:04:31Z","timestamp":1756310671315,"version":"3.37.3"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA023624"],"award-info":[{"award-number":["DA023624"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Michael E. DeBakey VA Medical Center"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.pbb.2019.172758","type":"journal-article","created":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T05:43:41Z","timestamp":1566020621000},"page":"172758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Rivastigmine does not alter cocaine-induced subjective effects or self-administration"],"prefix":"10.1016","volume":"185","author":[{"given":"M.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.D.","family":"Verrico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"R.","family":"De La Garza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.pbb.2019.172758_bb0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2009.04.015","article-title":"Modafinil for the treatment of cocaine dependence","volume":"104","author":"Anderson","year":"2009","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.pbb.2019.172758_bb0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/10884600600995317","article-title":"Medical complications of cocaine addiction: clinical implications for nursing practice","volume":"17","author":"Antai-Otong","year":"2006","journal-title":"J. Addict. Nurs."},{"issue":"4","key":"10.1016\/j.pbb.2019.172758_bb0015","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0306-4522(03)00378-6","article-title":"Cholinergic interneurons of the nucleus accumbens and dorsal striatum are activated by the self-administration of cocaine","volume":"120","author":"Berlanga","year":"2003","journal-title":"Neuroscience"},{"year":"2018","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results From the 2017","author":"Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration","key":"10.1016\/j.pbb.2019.172758_bb0020"},{"issue":"1","key":"10.1016\/j.pbb.2019.172758_bb0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pop.2010.11.004","article-title":"Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy","volume":"38","author":"Ciccarone","year":"2011","journal-title":"Prim. Care"},{"key":"10.1016\/j.pbb.2019.172758_bb0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.addbeh.2016.02.023","article-title":"The impact of non-concordant self-report of substance use in clinical trials research","volume":"58","author":"Clark","year":"2016","journal-title":"Addict. Behav."},{"key":"10.1016\/j.pbb.2019.172758_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/srep46665","article-title":"Cocaine cue-induced dopamine release in recreational cocaine users","volume":"7","author":"Cox","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.pbb.2019.172758_bb0040","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/0091-3057(82)90138-1","article-title":"Effects of haloperidol and physostigmine on self-administration of local anesthetics","volume":"17","author":"De La Garza","year":"1982","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.pbb.2019.172758_bb0045","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pbb.2007.12.010","article-title":"The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers","volume":"89","author":"De La Garza","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.pbb.2019.172758_bb0050","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1017\/S1461145708008456","article-title":"Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteers","volume":"11","author":"De La Garza","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2019.172758_bb0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pnpbp.2011.12.014","article-title":"Rivastigmine reduces \u201clikely to use methamphetamine\u201d in methamphetamine-dependent volunteers","volume":"37","author":"De La Garza","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pbb.2019.172758_bb0060","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv098","article-title":"Safety and preliminary efficacy of the acetylcholinesterase inhibitor huperzine a as a treatment for cocaine use disorder","volume":"19","author":"De La Garza","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.pbb.2019.172758_bb0065","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s11136-011-0012-7","article-title":"Determining the clinically important difference in visual analog scale scores in abuse liability studies evaluating novel opioid formulations","volume":"21","author":"Eaton","year":"2012","journal-title":"Qual. Life Res. Int. J. Qual. Life Asp. Treat. Care Rehab."},{"issue":"2","key":"10.1016\/j.pbb.2019.172758_bb0070","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/mp.2012.31","article-title":"Cocaine dependence: a fast-track for brain ageing?","volume":"18","author":"Ersche","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"10","key":"10.1016\/j.pbb.2019.172758_bb0075","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/jnnp.2006.099424","article-title":"Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer\u2019s disease","volume":"78","author":"Feldman","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7\u20138","key":"10.1016\/j.pbb.2019.172758_bb0080","first-page":"1003","article-title":"The cholinergic pathology in Alzheimer\u2019s disease\u2014discrepancies between clinical experience and pathophysiological findings","volume":"109","author":"Fr\u00f6lich","year":"2002","journal-title":"J. Neural Transm. (Vienna, Austria: 1996)"},{"issue":"1","key":"10.1016\/j.pbb.2019.172758_bb0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.drugalcdep.2009.09.010","article-title":"Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals","volume":"107","author":"Grasing","year":"2010","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.pbb.2019.172758_bb0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/FBP.0b013e3283428cd8","article-title":"Reversible and persistent decreases in cocaine self-administration after cholinesterase inhibition: different effects of donepezil and rivastigmine","volume":"22","author":"Grasing","year":"2011","journal-title":"Behav. Pharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2019.172758_bb0095","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/(SICI)1098-2396(199610)24:2<182::AID-SYN10>3.0.CO;2-0","article-title":"Evidence for an involvement of muscarinic cholinergic systems in the induction but not expression of behavioral sensitization to cocaine","volume":"24","author":"Heidbreder","year":"1996","journal-title":"Synapse (New York, N.Y.)"},{"key":"10.1016\/j.pbb.2019.172758_bb0100","doi-asserted-by":"crossref","unstructured":"Higley, M. J., & Picciotto, M. R. (2014). Neuromodulation by acetylcholine: examples from schizophrenia and depression. Curr. Opin. Neurobiol., 0, 88\u201395. doi:https:\/\/doi.org\/10.1016\/j.conb.2014.06.004.","DOI":"10.1016\/j.conb.2014.06.004"},{"issue":"10","key":"10.1016\/j.pbb.2019.172758_bb0105","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.1073\/pnas.0631749100","article-title":"Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine","volume":"100","author":"Hikida","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2019.172758_bb0110","unstructured":"IBM SPSS Statistics for Macintosh 2015. (n.d.)."},{"issue":"2\u20133","key":"10.1016\/j.pbb.2019.172758_bb0115","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0014-2999(93)90869-J","article-title":"Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus","volume":"238","author":"Imperato","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2019.172758_bb0120","series-title":"Psychopharmacology: The Fourth Generation of Progress","article-title":"The role of acetylcholine mechanisms in affective disorders","author":"Janowsky","year":"1995"},{"issue":"6","key":"10.1016\/j.pbb.2019.172758_bb0125","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00004714-199912000-00005","article-title":"Preferential cerebrospinal fluid acetylcholinesterase inhibition by rivastigmine in humans","volume":"19","author":"Kennedy","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.pbb.2019.172758_bb0130","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/2042098617750555","article-title":"An update on the safety of current therapies for Alzheimer\u2019s disease: focus on rivastigmine","volume":"9","author":"Khoury","year":"2018","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.pbb.2019.172758_bb0135","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/jat\/30.8.501","article-title":"Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration","author":"Kolbrich","year":"2006","journal-title":"J. Anal. Toxicol."},{"issue":"3","key":"10.1016\/j.pbb.2019.172758_bb0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.biopsych.2012.07.011","article-title":"Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine \u03b2-hydroxylase","volume":"73","author":"Kosten","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pbb.2019.172758_bb0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1755-5949.2010.00142.x","article-title":"Acetylcholine\u2013dopamine interactions in the pathophysiology and treatment of CNS disorders","volume":"16","author":"Lester","year":"2010","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.pbb.2019.172758_bb0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1023\/B:CEMN.0000012718.08443.60","article-title":"Cocaine treatment causes early and long-lasting changes in muscarinic and dopaminergic receptors","volume":"24","author":"Mac\u00eado","year":"2004","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.pbb.2019.172758_bb0155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pnpbp.2013.11.001","article-title":"Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers","volume":"50","author":"Mahoney","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.pbb.2019.172758_bb0160","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(95)00401-B","article-title":"Extracellular acetylcholine is increased in the nucleus accumbens following the presentation of an aversively conditioned taste stimulus","volume":"688","author":"Mark","year":"1995","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.pbb.2019.172758_bb0165","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s002130050918","article-title":"Self-administration of cocaine increases the release of acetylcholine to a greater extent than response-independent cocaine in the nucleus accumbens of rats","volume":"143","author":"Mark","year":"1999","journal-title":"Psychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.pbb.2019.172758_bb0170","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2008.10.016","article-title":"Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial","volume":"101","author":"Mooney","year":"2009","journal-title":"Drug Alcohol Depend."},{"issue":"2\u20133","key":"10.1016\/j.pbb.2019.172758_bb0175","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.drugalcdep.2010.07.022","article-title":"Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients","volume":"113","author":"Oliveto","year":"2011","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.pbb.2019.172758_bb0180","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/ciia.2007.2.1.17","article-title":"Rivastigmine in the treatment of Alzheimer\u2019s disease: an update","volume":"2","author":"Onor","year":"2007","journal-title":"Clin. Interv. Aging"},{"issue":"2","key":"10.1016\/j.pbb.2019.172758_bb0185","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neubiorev.2005.04.016","article-title":"The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?","volume":"30","author":"Pierce","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.pbb.2019.172758_bb0190","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0006-8993(00)02865-1","article-title":"Aversive hypothalamic stimulation releases acetylcholine in the nucleus accumbens, and stimulation-escape decreases it","volume":"888","author":"Rada","year":"2001","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.pbb.2019.172758_bb0195","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0006-8993(91)91616-9","article-title":"Microdialysis evidence that acetylcholine in the nucleus accumbens is involved in morphine withdrawal and its treatment with clonidine","volume":"561","author":"Rada","year":"1991","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.pbb.2019.172758_bb0200","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.pbb.2004.09.011","article-title":"In alcohol-treated rats, naloxone decreases extracellular dopamine and increases acetylcholine in the nucleus accumbens: evidence of opioid withdrawal","volume":"79","author":"Rada","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.pbb.2019.172758_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2012.06.028","article-title":"A feud that wasn\u2019t: acetylcholine evokes dopamine release in the striatum","volume":"75","author":"Surmeier","year":"2012","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.pbb.2019.172758_bb0210","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1517\/13543784.2013.836488","article-title":"Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications","volume":"22","author":"Verrico","year":"2013","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"8","key":"10.1016\/j.pbb.2019.172758_bb0215","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/sj.npp.1301585","article-title":"The role of acetylcholine in cocaine addiction","volume":"33","author":"Williams","year":"2008","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2019.172758_bb0220","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0304-3940(94)90906-7","article-title":"Choline acetyltransferase activity is reduced in rat nucleus accumbens after unlimited access to self-administration of cocaine","volume":"180","author":"Wilson","year":"1994","journal-title":"Neurosci. Lett."},{"issue":"Suppl. 1","key":"10.1016\/j.pbb.2019.172758_bb0225","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1360-0443.2005.00992.x","article-title":"A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments","volume":"100","author":"Winhusen","year":"2005","journal-title":"Addiction"},{"issue":"15","key":"10.1016\/j.pbb.2019.172758_bb0230","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1523\/JNEUROSCI.22-15-06347.2002","article-title":"Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice","volume":"22","author":"Zhang","year":"2002","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.pbb.2019.172758_bb0235","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02245069","article-title":"Alterations in striatal acetylcholine overflow by cocaine, morphine, and MK-801: relationship to locomotor output","volume":"115","author":"Zocchi","year":"1994","journal-title":"Psychopharmacology"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305718306099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305718306099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T06:05:22Z","timestamp":1695103522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305718306099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":47,"alternative-id":["S0091305718306099"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2019.172758","relation":{},"ISSN":["0091-3057"],"issn-type":[{"type":"print","value":"0091-3057"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rivastigmine does not alter cocaine-induced subjective effects or self-administration","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2019.172758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172758"}}